TrialAntimicrobial agents and chemotherapy2016

Clinical Resistance to Velpatasvir (GS-5816), a Novel Pan-Genotypic Inhibitor of the Hepatitis C Virus NS5A Protein.

Eric J Lawitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.